Abstract:Background Uterine cancers are associated with a high risk of venous thromboembolism. The American Society of Clinical Oncology practice guidelines recommend all patients undergoing pelvic surgery for cancer receive extended pharmacological thromboprophylaxis with the duration dependent on risk. However, risk stratification for patients with uterine cancer is not clearly defined. The Caprini score is the most widely used risk assessment model but it has been found to have limited utility in the gynecologic oncology population. A modified Caprini score has been explored in other populations. The Khorana score is an additional risk assessment model which has not been studied in this context. Objective Our objective was to evaluate the ability of a modified Caprini model as well as the Khorana score to risk stratify patients with uterine cancer for postoperative venous thromboembolism within 90 days of surgery. Study Design Following IRB approval, a retrospective cohort study was performed and all patients with uterine cancer who underwent a hysterectomy over a 4-year period were included. The Caprini and Khorana scores were calculated for each patient. The Caprini score cutoff for highest risk was evaluated at ≥7, ≥8 and ≥9 ("modified Caprini") and the Khorana score cutoff was evaluated at ≥2 and ≥3. To determine the prognostic utility of each score as well as other clinico-pathologic criteria on development of venous thromboembolism, univariate analysis was performed using independent t test, chi-square test or Fisher's exact test; multivariate analysis was performed using logistic regression. Results A total of 954 patients were included, the rate of venous thromboembolism was 1.7% (16/954). Minimally invasive surgical approach was utilized in 90.5% (863/954) of patients. The mean Caprini score of patients with venous thromboembolism was 10.3 compared to 8.1 for the patients without (p<0.0001, 95%CI 1.17-3.33). The mean Khorana score of the venous thromboembolism group was 2.4 versus 1.9 (p=0.03, 95%CI 0.04-0.82). Both the Caprini and Khorana scores were found to be associated with venous thromboembolism, but only a Caprini score with cutoff ≥8 or ≥9 was statistically significant (RR 31.25, 95%CI 1.88-519.49; RR 4.59, 95%CI 1.49-14.13 respectively), with high accuracy based on area under the curve (0.75 and 0.68, respectively). Of the minimally invasive subgroup, 11.7% (101/863) had same-day discharge with no postoperative thromboprophylaxis; none of these patients developed venous thromboembolism. Despite laparotomy patients receiving extended prophylaxis (30 days), the rate of venous thromboembolism was more than three times that of the minimally invasive group (5.49% vs 1.7%). Advanced stage and leukocytosis were noted to be independent risk factors for venous thromboembolism. Conclusions Our study suggests that using a modified Caprini score could help identify the highest risk patients who would benefit from prolonged thromboprophylaxis, reduce the incidence of postoperative venous thromboembolism as well as minimize the cost and harm of overtreatment. These findings need to be validated in a prospective manner and further research is needed to determine the optimal duration of therapy.

A Prospective Study Evaluating Patterns of Responses to the Caprini Score to Prevent Venous Thromboembolism After Interventional Treatment for Varicose Veins

Assessing the Risk for Development of Deep Vein Thrombosis among Chinese Patients Using the 2010 Caprini Risk Assessment Model: A Prospective Multicenter Study.

Validation of a Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment

The evolution of the Caprini score

Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis

Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis

Systematic review of venous thromboembolism risk categories derived from Caprini score

Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty

The Validation and Modification of the Caprini Risk Assessment Model for Evaluating Venous Thromboembolism after Joint Arthroplasty

Outcome of preventive nursing intervention, prophylactic anticoagulation and the use of the Caprini score on venous thromboembolism after varicose vein surgery

External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs

Efficacy of Caprini risk assessment model in predicting venous thromboembolism risks among Asian surgical patients

Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review

Postoperative Venous Thromboembolism Risk Stratification in Patients with Uterine Cancer.

Protocol for prophylaxis of venous thromboembolism in varicose vein surgery of the lower limbs

Risk Factors and Assessment System Analysis of Venous Thromboembolism in Joint Surgery Patients

Age is a Risk Factor for Poor Knowledge About Venous Thromboembolism Treatment

Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)

[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores]

External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer

Risk adjusted venous thromboembolism prophylaxis following pancreatic surgery